Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 9Active not recruiting 8Not yet recruiting 7Withdrawn 3Unknown 2Suspended 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Biliary Carcinoma 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × zimberelimab × Clear all
NCT06107114 2023-11-22

CZCNRHNSCC

Sun Yat-sen University

Phase 2 Unknown
52 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05540483 2022-09-16

RIGHT

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
31 enrolled
Gastrointestinal

Biliary Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡